Eisai taps FORMA for discovery of novel oncology drugs
This article was originally published in Scrip
Executive Summary
Eisai's US subsidiary has entered into a collaboration with the private US firm FORMA Therapeutics for the discovery of small molecule therapeutics against novel targets.